A Genetic Variant in SLC28A3, Rs56350726, Is Associated With Progression to Castration-Resistant Prostate Cancer in a Korean Population With Metastatic Prostate Cancer

Oncotarget - United States
doi 10.18632/oncotarget.18298
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Prolonged Therapy With Cabazitaxel in an Octogenarian With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2012English

Evaluating Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer With Imaging

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

Clinical Medicine Insights: Oncology
Oncology
2016English

Molecular Mechanisms of Castration-Resistant Prostate Cancer Progression

Future Oncology
MedicineCancer ResearchOncology
2009English

Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients With Oligo-Progression During Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review

European Oncology and Haematology
OncologyHematology
2012English

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology
Oncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy